Structures by: Kannan M.
Total: 11
C22H15IN2O2
C22H15IN2O2
Organic & biomolecular chemistry (2015) 13, 9 2786-2792
a=9.5097(4)Å b=10.4987(4)Å c=19.3484(7)Å
α=90.00° β=96.431(2)° γ=90.00°
C23H15ClFNO2
C23H15ClFNO2
RSC Adv. (2015)
a=27.292(5)Å b=10.0001(19)Å c=15.408(3)Å
α=90° β=116.511(10)° γ=90°
2,4,6-Trimethyl-3,5-bis[(phenylcarbonothioyl)sulfanylmethyl]benzyl benzenecarbodithioate
C33H30S6
Acta Crystallographica Section E (2010) 66, 6 o1382
a=9.5698(3)Å b=21.7668(10)Å c=15.3823(8)Å
α=90.00° β=94.819(2)° γ=90.00°
3-Benzyl-6-benzylamino-1-methyl-5-nitro-1,2,3,4-tetrahydropyrimidine
C19H22N4O2
Acta Crystallographica Section E (2010) 66, 3 o515
a=29.2634(12)Å b=29.2634Å c=10.4916(8)Å
α=90.00° β=90.00° γ=120.00°
Ethyl 2-(6-amino-5-cyano-3,4-dimethyl-2<i>H</i>,4<i>H</i>- pyrano[2,3-<i>c</i>]pyrazol-4-yl)acetate
C13H16N4O3
Acta Crystallographica Section E (2010) 66, 5 o1242
a=6.961(5)Å b=7.373(5)Å c=14.535(5)Å
α=86.405(5)° β=85.183(5)° γ=65.726(5)°
Bis(μ-phenyltellurido-κ^2^<i>Te</i>:<i>Te</i>)bis[tetracarbonylrhenium(I)]
C40H20O16Re4Te4
Acta Crystallographica Section E (2010) 66, 5 m558-m559
a=9.8062(13)Å b=16.3418(15)Å c=17.1000(14)Å
α=106.593(7)° β=99.932(9)° γ=105.572(10)°
Ethyl 6-amino-5-cyano-2,4-bis(4-methylphenyl)-4<i>H</i>-pyran-3-carboxylate
C23H22N2O3
Acta Crystallographica Section E (2010) 66, 10 o2536
a=8.3485(2)Å b=11.4057(3)Å c=11.6689(3)Å
α=72.902(2)° β=72.690(2)° γ=89.182(2)°
6-Amino-3,4-dimethyl-4-phenyl-2<i>H</i>,4<i>H</i>-pyrano[2,3-<i>c</i>]pyrazole- 5-carbonitrile
C15H14N4O
Acta Crystallographica Section E (2011) 67, 4 o956
a=6.682(5)Å b=9.347(5)Å c=11.078(5)Å
α=99.213(5)° β=102.740(5)° γ=97.767(5)°
6,8-dichloro-<i>N</i>-methyl-3-nitro-4-nitromethyl-4<i>H</i>-chromen-2-amine
C11H9Cl2N3O5
Acta Crystallographica Section E (2011) 67, 4 o898-o899
a=8.7426(7)Å b=9.2727(7)Å c=9.3420(7)Å
α=70.017(7)° β=72.609(7)° γ=87.579(6)°
3-({[(1-Phenylethyl)sulfanyl]methanethioyl}sulfanyl)propanoic acid
C12H14O2S3
Acta Crystallographica Section E (2011) 67, 12 o3352
a=13.6280(8)Å b=10.2908(5)Å c=10.7299(5)Å
α=90.00° β=113.039(2)° γ=90.00°
<i>N</i>-(4-Chlorophenyl)-1-(5-{[(2-phenylethenyl)sulfonyl]methyl}- 1,3,4-oxadiazol-2-yl)methanesulfonamide
C18H16ClN3O5S2
Acta Crystallographica Section E (2012) 68, 10 o2954
a=21.1387(12)Å b=5.4443(2)Å c=18.3484(11)Å
α=90.00° β=107.810(7)° γ=90.00°